Goodwin Procter advised Adicet Bio, Inc. on the deal.Adicet Bio, Inc. (Nasdaq: ACET) announced its underwritten public offering of 7,187,500 shares of its common stock, including the…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
